Search results
Psoriasis and Depression: What’s the Connection?
Verywell Health via Yahoo News· 3 days agoPsoriasis is a chronic skin condition that can affect your mood, and many people with psoriasis experience depression. Here’s what you can do if you feel...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 7 days agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 1 day agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent ...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 10 hours agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 6 days agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
Why Do I Have Itchy Feet During Pregnancy?
Parents via Yahoo News· 3 days agoAlthough people often find that pregnancy offers relief from itchy psoriasis symptoms, for about 10% to 20% of pregnant people, pregnancy makes psoriasis
Experts Share How to Do a Hot Oil Treatment for Hair at Home
Prevention via AOL· 3 days agoResearch shows that certain oils may boost blood circulation, which in turn may stimulate scalp hair...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 4 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 6 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 3 days agoA decision on approval is expected in the fourth quarter of 2024.